Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The homocysteine methylation pathway consists of a set of enzymes responsible for the remethylation of homocysteine to methionine, a critical process in one-carbon metabolism. This pathway is essential for maintaining cellular methylation reactions and regulating homocysteine levels, which are linked to cardiovascular and neurological health. Key enzymes include Methionine Synthase (MS), Betaine-Homocysteine Methyltransferase (BHMT), and Methylenetetrahydrofolate Reductase (MTHFR). Dysregulation of this pathway can lead to elevated plasma homocysteine, associated with increased risk of vascular disease and other pathologies.
Enzymatic catalysis in homocysteine remethylation, cofactor supplementation to enhance enzyme activity, substrate provision for enzymatic reactions
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homocysteine Methylation Pathway Enzymes (HMP Enzymes).